GAMMA Investing LLC Has $42,000 Stake in Teleflex Incorporated (NYSE:TFX)

GAMMA Investing LLC raised its position in shares of Teleflex Incorporated (NYSE:TFX) by 131.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 171 shares of the medical technology company’s stock after acquiring an additional 97 shares during the period. GAMMA Investing LLC’s holdings in Teleflex were worth $42,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. grew its holdings in shares of Teleflex by 11.5% during the 4th quarter. Goldman Sachs Group Inc. now owns 171,959 shares of the medical technology company’s stock worth $42,876,000 after purchasing an additional 17,669 shares in the last quarter. Vanguard Group Inc. raised its position in Teleflex by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 5,454,016 shares of the medical technology company’s stock valued at $1,359,904,000 after purchasing an additional 57,132 shares in the last quarter. Nomura Holdings Inc. bought a new stake in Teleflex during the fourth quarter worth $237,000. Mather Group LLC. acquired a new stake in shares of Teleflex in the 1st quarter valued at $59,000. Finally, Bridge Creek Capital Management LLC increased its stake in shares of Teleflex by 2.7% in the 1st quarter. Bridge Creek Capital Management LLC now owns 16,263 shares of the medical technology company’s stock valued at $3,678,000 after purchasing an additional 430 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Truist Financial raised their price objective on Teleflex from $247.00 to $255.00 and gave the company a “hold” rating in a research note on Monday. Stephens raised their price target on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Royal Bank of Canada upped their price objective on shares of Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Finally, Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $268.86.

Teleflex Stock Down 0.4 %

Shares of NYSE TFX opened at $234.14 on Friday. The company has a 50 day simple moving average of $240.63 and a 200 day simple moving average of $222.85. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.58 and a quick ratio of 1.44. Teleflex Incorporated has a 1 year low of $177.63 and a 1 year high of $257.85. The firm has a market cap of $11.03 billion, a PE ratio of 42.04, a price-to-earnings-growth ratio of 2.15 and a beta of 1.16.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company’s revenue was up .9% on a year-over-year basis. During the same period in the prior year, the company posted $3.41 EPS. On average, research analysts forecast that Teleflex Incorporated will post 13.97 EPS for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were given a $0.34 dividend. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.58%. Teleflex’s dividend payout ratio (DPR) is currently 24.42%.

Insider Activity

In related news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.43% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.